Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Blinded, Comparative Study of Phase II Allantoic Split Inactivated Seasonal Influenza Vaccine in Healthy Adults

NCT03016143 is registered in ClinicalTrials.gov with Research Institute for Biological Safety Problems as lead sponsor.

NCT NCT03016143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03016143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Blinded, Comparative Study of Phase II Allantoic Split Inactivated Seasonal Influenza Vaccine in Healthy Adults
Lead sponsor
Research Institute for Biological Safety Problems
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2016
Completion date
December 31, 2016
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza